Medicare Plans Are Discouraging Generics Use

AAM Urges Policy Update Following Avalere Report

An AAM-sponsored study by researcher Avalere Health has concluded that Medicare Part D policy changes have led to generics being placed on non-generic tiers 53% of the time in 2020, with generics placed on the ‘preferred generic’ Tier 1 just 10% of the time.

Dollars_Pills
Avalere’s study suggests that US patients are being forced to pay more for generics • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin